BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18038462)

  • 1. Genomewide study of multiple sclerosis.
    Matesanz F; Fernández O; Alcina A
    N Engl J Med; 2007 Nov; 357(21):2200; author reply 2200-1. PubMed ID: 18038462
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomewide study of multiple sclerosis.
    Ramagopalan SV; Anderson C; Sadovnick AD; Ebers GC
    N Engl J Med; 2007 Nov; 357(21):2199-200; author reply 2200-1. PubMed ID: 18032773
    [No Abstract]   [Full Text] [Related]  

  • 3. Old suspects found guilty--the first genome profile of multiple sclerosis.
    Peltonen L
    N Engl J Med; 2007 Aug; 357(9):927-9. PubMed ID: 17660531
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomewide study of multiple sclerosis.
    Chaudhuri A; Behan PO
    N Engl J Med; 2007 Nov; 357(21):2200; author reply 2200-1. PubMed ID: 18038461
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility to multiple sclerosis: the role of interleukin genes.
    Marrosu MG
    Lancet Neurol; 2007 Oct; 6(10):846-7. PubMed ID: 17884670
    [No Abstract]   [Full Text] [Related]  

  • 6. IL7RA polymorphisms and susceptibility to multiple sclerosis.
    O'Doherty C; Kantarci O; Vandenbroeck K
    N Engl J Med; 2008 Feb; 358(7):753-4. PubMed ID: 18272905
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of variation in the IL7RA and IL2RA genes in atopic dermatitis.
    Hoffjan S; Beygo J; Akkad DA; Parwez Q; Petrasch-Parwez E; Epplen JT
    J Dermatol Sci; 2009 Aug; 55(2):138-40. PubMed ID: 19523791
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk alleles for multiple sclerosis identified by a genomewide study.
    ; Hafler DA; Compston A; Sawcer S; Lander ES; Daly MJ; De Jager PL; de Bakker PI; Gabriel SB; Mirel DB; Ivinson AJ; Pericak-Vance MA; Gregory SG; Rioux JD; McCauley JL; Haines JL; Barcellos LF; Cree B; Oksenberg JR; Hauser SL
    N Engl J Med; 2007 Aug; 357(9):851-62. PubMed ID: 17660530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
    J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of multiple sclerosis and its experimental models.
    Olsson T; Hillert J
    Curr Opin Neurol; 2008 Jun; 21(3):255-60. PubMed ID: 18451707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD25 gene polymorphism and multiple sclerosis.
    Alsahebfosoul F; Salehi R; Ghaffari S; Jahanbani-Ardakani H; Etemadifar M; Kazemi M; Abtahi SH
    Mult Scler Relat Disord; 2017 Nov; 18():117-118. PubMed ID: 29141792
    [No Abstract]   [Full Text] [Related]  

  • 12. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
    Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
    Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population.
    Kurreeman FA; Daha NA; Chang M; Catanese JJ; Begovich AB; Huizinga TW; Toes RE
    Ann Rheum Dis; 2009 Nov; 68(11):1789-90. PubMed ID: 19822714
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis: light at the end of the tunnel.
    Sawcer S; Compston A
    Eur J Hum Genet; 2006 Mar; 14(3):257-8. PubMed ID: 16391554
    [No Abstract]   [Full Text] [Related]  

  • 15. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
    Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
    Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin 23 receptor gene in multiple sclerosis: a case-control study.
    Roos IM; Kockum I; Hillert J
    J Neuroimmunol; 2008 Feb; 194(1-2):173-80. PubMed ID: 18164077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
    Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
    J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
    Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
    J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7Ralpha and multiple sclerosis risk.
    Harley JB
    Nat Genet; 2007 Sep; 39(9):1053-4. PubMed ID: 17728770
    [No Abstract]   [Full Text] [Related]  

  • 20. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis.
    Begovich AB; Chang M; Caillier SJ; Lew D; Catanese JJ; Wang J; Hauser SL; Oksenberg JR
    Hum Immunol; 2007 Nov; 68(11):934-7. PubMed ID: 18082575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.